974 - Real World Experience of Posaconazole Therapeutic Drug Monitoring in Oncology Patients: Clinical Implications of Hypoalbuminemia as a Predictor of Subtherapeutic Posaconazole Levels

Presenting Author(s)

• 

  Yanina Pasikhova, PharmD

  Infectious Diseases/Antimicrobial Stewardship Pharmacist
  Moffitt Cancer Center
  Tampa, FL, United States

  Slides

Co-Author(s)

• JG

  John Greene, MD

  Section Chief
  Moffitt Cancer Center
  Tampa, FL, United States
• AM

  Austin R. Morrison, PharmD

  Infectious Diseases/Antimicrobial Stewardship Pharmacist,
  Moffitt Cancer Center
  Detroit, Michigan, United States
• GH

  Guy Handley, MD

  Assistant Professor
  University of South Florida
  Tampa, Florida, United States